American Oriental Bioengineering Cash Flow - Annual (OTCMKTS:AOBI)

Add to My Stocks
$2.5 $0 (0%) AOBI stock closing price Sep 18, 2018 (Closing)

The American Oriental Bioengineering cash flow statement helps investors understand how well the company is managing its cash flows. Financials statements like the American Oriental Bioengineering income statement and American Oriental Bioengineering balance sheet show that the company has profits and debt, while the cash flow statement provides details of cash flow movments. American Oriental Bioengineering had cash and cash equivalents of $52.62M at beginning of the year and $7.09M at year end for 2012. American Oriental Bioengineering cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. American Oriental Bioengineering had an outflow of $-46.45M from operating activities, $-15.48M spend due to financing activities, and $15.18M inflow due to investing activities for 2012.

View details of American Oriental Bioengineering cash flows for latest & last 10 financial years
show more
Fiscal year is Jan - Dec20122011201020092008
Net Income Cash Flow
-59.72M-68.49M16.31M41.3M47.8M
Depreciation Depletion Amortization Cash-Flow12.72M13.38M13.63M13.39M10.54M
Net Increase (Decrease) in Assets Liabilities-7.16M12.18M-24.56M-29.18M-
Cash From (used in) Discontinued Operations-----
Other Adjustments Net7.71M72.87M2.64M-0.09M18.79M
Net Cash from (used by) Operating Activities
-46.45M29.95M8.03M25.4M77.75M
Increase (Decrease) in Prop Plant And Equipment-18.66M-36.39M-6.06M-3.88M-73.12M
Acquisition Disposition of Subsidiaires-----53.05M
Increase (Decrease) in Investments18.32M5.15M-0.05M-0.23M-22.37M
Other Cash Inflow (Outflow) from Investment Activities15.51M-41.32M-0.04M5.27M-108.81M
Net Cash from (used by) Investment Activities
15.18M-71.94M-6.16M1.15M-257.37M
Issuance (Purchase) of Equity Shares-1.27M-0.79M---
Issuance (Repayment) of Debt Securities-18.47M-3.16M-3.87M-110.35M
Increase (Decrease) in Bank & Other Borrowings10.51M-0.57M---
Payment of Dividends & Other Cash Distributions-----
Other Cash from (used by) Financing Activities-6.25M----29.99M
Net Cash from (used by) Financing Activities
-15.48M-4.26M-3.87M-80.94M
Effect of Exchange Rate Changes on Cash1.22M4.31M5.44M-2.89M
Net Change in Cash & Cash Equivalents
-45.53M-41.94M3.44M26.56M-95.77M
Cash & Equivalents at Beginning of Year52.62M94.56M91.12M-166.41M
Cash & Equivalents at Year End7.09M52.62M94.56M-70.63M
All figures in USD. M: Millions of USD, B: Billions of USD.

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The American Oriental Bioengineering stock price history and American Oriental Bioengineering stock comparison chart inevitably reflect its cash flow situation.

  • American Oriental Bioengineering has cash of $7.09M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the American Oriental Bioengineering stock price.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $-46.45M for AOBI.
  • Cash from investing stood at a positive value of $15.18M for AOBI stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. American Oriental Bioengineering spent $-15.48M from financing activities, in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For American Oriental Bioengineering Cash Flow

Annual Cash Flow Statements For American Oriental Bioengineering, Inc. Peers

Biostar Pharma cash flow, Lotus Pharma cash flow, Vertical Health cash flow